This company listing is no longer active
Oncodesign Société Anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Key information
232.0%
Debt to equity ratio
€26.25m
Debt
| Interest coverage ratio | n/a |
| Cash | €25.45m |
| Equity | €11.31m |
| Total liabilities | €47.75m |
| Total assets | €59.06m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 16O's short term assets (€42.3M) exceed its short term liabilities (€26.5M).
Long Term Liabilities: 16O's short term assets (€42.3M) exceed its long term liabilities (€21.3M).
Debt to Equity History and Analysis
Debt Level: 16O's net debt to equity ratio (7.1%) is considered satisfactory.
Reducing Debt: 16O's debt to equity ratio has increased from 5.5% to 232% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 16O has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 16O has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.